Phase 2 Head and Neck Cancer Trial, Recruiting (NCT06289049)

Phase 2 Head and Neck Cancer Trial, Recruiting NCT06289049 Sponsor: University of Alberta Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06289049 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older of any gender
People who have had any type or stage of head and neck cancer, regardless of what treatment they received
People who are at least one year past the end of their cancer treatment and have a certain minimum level of shoulder movement (the trial site will check whether shoulder flexibility meets the required levels)
People who do not have unmanaged health conditions, and who are not dealing with alcohol or drug misuse
People whose oncologist and a certified exercise professional have approved them to take part in exercise
People who are able to understand and communicate in English

Who may not be able to join:

People who have already been doing strength training exercise at least two days per week in the past month, meeting the Canadian Physical Activity guidelines for muscle and bone strengthening
People who are currently taking part in another exercise study or a clinical drug trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Kerry Courneya, University of Alberta

Phone: 7804922829

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06289049

Sponsor: University of Alberta

Phase: Phase 2

Status: Recruiting

Condition: Head and Neck Cancer

Trial contact: 7804922829

More information: https://clinicaltrials.gov/study/NCT06289049

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older of any gender
People who have had any type or stage of head and neck cancer, regardless of what treatment they received
People who are at least one year past the end of their cancer treatment and have a certain minimum level of shoulder movement (the trial site will check whether shoulder flexibility meets the required levels)
People who do not have unmanaged health conditions, and who are not dealing with alcohol or drug misuse
People whose oncologist and a certified exercise professional have approved them to take part in exercise
People who are able to understand and communicate in English

Who may not be able to join:

People who have already been doing strength training exercise at least two days per week in the past month, meeting the Canadian Physical Activity guidelines for muscle and bone strengthening
People who are currently taking part in another exercise study or a clinical drug trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

University of Alberta

Registry

ClinicalTrials.gov

Start date

17 February 2025

Est. completion

1 June 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Recruitment rate; Adherence to a heavy lifting strength training program; Completion of maximal strength testing; Followup assessment rate; Safety

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov